Home
/
Core Scientific, Inc./tx
/
Financials
/
Quarterly
Core Scientific, Inc./tx — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Core Scientific, Inc./tx filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$81.10M
Mar 2, 2026
Q2
2025
Jun 30, 2025
$78.63M
Mar 2, 2026
Q1
2025
Mar 31, 2025
$79.53M
Mar 2, 2026
Q3
2025
Sep 30, 2024
$95.35M
Mar 2, 2026
Q2
2025
Jun 30, 2024
$141.10M
Mar 2, 2026
Q1
2025
Mar 31, 2024
$179.29M
Mar 2, 2026
Q3
2024
Sep 30, 2023
$112.90M
Nov 6, 2024
Q2
2024
Jun 30, 2023
$126.91M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$120.66M
May 9, 2024
Q3
2023
Sep 30, 2022
$162.57M
Nov 6, 2023
Q2
2023
Jun 30, 2022
$163.97M
Aug 4, 2023
Q1
2023
Mar 31, 2022
$192.52M
May 15, 2023
Q3
2022
Sep 30, 2021
$113.14M
Nov 22, 2022
Q2
2022
Jun 30, 2021
$75.30M
Aug 22, 2022
Q1
2022
Mar 31, 2021
$54.25M
May 13, 2022
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($144.03M)
Mar 2, 2026
Q2
2025
Jun 30, 2025
($936.80M)
Mar 2, 2026
Q1
2025
Mar 31, 2025
$576.25M
Mar 2, 2026
Q3
2025
Sep 30, 2024
($455.26M)
Mar 2, 2026
Q2
2025
Jun 30, 2024
($902.16M)
Mar 2, 2026
Q1
2025
Mar 31, 2024
$210.69M
Mar 2, 2026
Q3
2024
Sep 30, 2023
($41.15M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($9.26M)
Aug 7, 2024
Q3
2023
Mar 31, 2023
($388.0K)
Nov 6, 2023
Q1
2024
Mar 31, 2023
($388.0K)
May 9, 2024
Q2
2023
Mar 31, 2023
($388.0K)
Aug 4, 2023
Q3
2023
Sep 30, 2022
($434.79M)
Nov 6, 2023
Q2
2023
Jun 30, 2022
($810.48M)
Aug 4, 2023
Q1
2023
Mar 31, 2022
($466.20M)
May 15, 2023
Q3
2022
Sep 30, 2021
($16.63M)
Nov 22, 2022
Q2
2022
Jun 30, 2021
($3.41M)
Aug 22, 2022
Q1
2022
Mar 31, 2021
$6.85M
May 13, 2022
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($54.79M)
Mar 2, 2026
Q2
2025
Jun 30, 2025
($26.28M)
Mar 2, 2026
Q1
2025
Mar 31, 2025
($47.04M)
Mar 2, 2026
Q3
2025
Sep 30, 2024
($41.22M)
Mar 2, 2026
Q2
2025
Jun 30, 2024
($90.68M)
Mar 2, 2026
Q1
2025
Mar 31, 2024
$55.23M
Mar 2, 2026
Q3
2024
Sep 30, 2023
($12.04M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
$9.47M
Aug 7, 2024
Q3
2023
Mar 31, 2023
$7.60M
Nov 6, 2023
Q1
2024
Mar 31, 2023
$7.60M
May 9, 2024
Q2
2023
Mar 31, 2023
$7.60M
Aug 4, 2023
Q3
2023
Sep 30, 2022
($401.37M)
Nov 6, 2023
Q2
2023
Jun 30, 2022
($1.05B)
Aug 4, 2023
Q1
2023
Mar 31, 2022
($26.72M)
May 15, 2023
Q3
2022
Sep 30, 2021
$4.78M
Nov 22, 2022
Q2
2022
Jun 30, 2021
$15.53M
Aug 22, 2022
Q1
2022
Mar 31, 2021
$9.03M
May 13, 2022